Loading...
OTCM
YTENQ
Market cap0kUSD
Oct 07, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-100.00%
IPO
-100.00%
Name

Yield10 Bioscience Inc

Chart & performance

D1W1MN
OTCM:YTENQ chart
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
100.00%
Rev. gr., 5y
-35.94%
Revenues
60k
-86.67%
3,678,2042,781,0004,590,0001,683,0001,555,0001,425,000448,0001,425,00042,316,0005,394,0002,800,0002,594,0001,159,000944,000556,000806,000799,000614,000450,00060,000
Net income
-14m
L+6.55%
-5,054,511-7,625,427-16,062,000-27,875,000-36,005,000-37,957,000-38,803,000-38,785,0003,630,000-30,506,000-29,534,000-23,681,000-7,604,000-9,396,000-9,185,000-12,956,000-10,206,000-11,031,000-13,566,000-14,455,000
CFO
-10m
L-11.72%
-980,667-4,394,184-3,603,000-10,900,000-18,392,000-25,759,000-31,995,000-31,731,000-31,736,000-26,648,000-24,244,000-21,863,000-14,700,000-8,202,000-8,754,000-8,654,000-8,659,000-9,253,000-11,404,000-10,068,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Yield10 Bioscience, Inc. is an agricultural biotechnology firm dedicated to creating advanced solutions that can significantly boost crop productivity across the United States and Canada. Utilizing its proprietary Trait Factory – an innovative gene discovery platform – the company develops enhanced varieties of oilseed Camelina sativa for exclusive seed products. Additionally, it identifies valuable genetic characteristics applicable to both the agricultural and food sectors. Yield10 Bioscience maintains licensing agreements with several key industry players, including GDM Seeds, J. R. Simplot, Forage Genetics International, LLC, and Bayer AG. The company, incorporated in 1992, rebranded from Metabolix, Inc. to Yield10 Bioscience, Inc. in January 2017. Its corporate headquarters are located in Woburn, Massachusetts.

Key people

Robert L. Van Nostrand
Chairman of the Board, Independent Director · since 2013
Oliver P. Peoples
President, Chief Executive Officer, Director · since 2016
Charles B. Haaser
Chief Accounting Officer, Vice President - Finance · since 2016
Lynne H. Brum
Vice President - Planning and Communications · since 2016
Kristi D Snell
Chief Science Officer, Vice President - Research · since 2016
Sarah P. Cecil
General Counsel, Secretary · since 2006
Richard William Hamilton
Director · since 2017
Joseph H. Shaulson
Director · since 2016
Anthony J. Sinskey
Independent Director · since 1992
URL
https://www.yield10bio.com/
IPO date
Nov 10, 2006
Employees
30
Domiciled in
US
Incorporated in
US
Legal address
C/O The Corporation Trust Company
Corporation Trust Center
1209 Orange Street
Wilmington, DE 19801
US
Headquarters
21 Erie Street
Cambridge, MA 02139
US
Previous name
Metabolix, Inc.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT